1. Cost-effectiveness evaluation of pre-counseling telephone interviews before face-to-face genetic counseling in cancer genetics
- Author
-
François Lecoquierre, Gaëlle Collet, Afane Brahimi, Jean-Christophe Thery, Elodie Lacaze, Fanny Cohen, Nathalie Parodi, Thierry Frebourg, Pascaline Berthet, Kévin Cassinari, Céline Gasnier, Isabelle Tennevet, and Zoé Neviere
- Subjects
0301 basic medicine ,Cancer Research ,medicine.medical_specialty ,Cost effectiveness ,Cost-Benefit Analysis ,Genetic counseling ,Breast Neoplasms ,Genetic Counseling ,Context (language use) ,030105 genetics & heredity ,Interviews as Topic ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Genetics ,medicine ,Humans ,Genetic Predisposition to Disease ,Medical history ,Psychiatry ,Genetics (clinical) ,Ovarian Neoplasms ,business.industry ,Cancer ,Geneticist ,medicine.disease ,Human genetics ,Telephone ,Oncology ,030220 oncology & carcinogenesis ,Family medicine ,Female ,business - Abstract
One of the main challenges in cancer genetics is responding to the exponential demand for genetic counseling, especially in patients with breast and/or ovarian cancer. To address this demand, we have set up a new procedure, based on pre-genetic counseling telephone interviews (PTI) followed by routing of patients: D1, a PTI is scheduled within 14 days; D7-D14, genetic counselors perform a 20 min PTI in order to establish a pre-genetic counseling file, by collecting personal and family medical history via a structured questionnaire and; D10-17, routing: pre-genetic counseling appointment files are analyzed by a cancer geneticist with 3 possible conclusions: (a) priority face-to-face genetic counseling (FTFGC) appointment with a cancer geneticist, if the genetic test results have an immediate therapeutic impact; (b) non-priority FTFGC with a genetic counselor, or (c) no FTFGC required or substitution by a more appropriate index case. In the context of breast and/or ovarian cancer, 1012 patients received PTIs, 39.1% of which did not lead to FTFGC. The mean delay for non-priority FTFGC was maintained at 18 weeks and priority FTFGC appointments were guaranteed within 8 weeks. The required resources for 1012 patients was estimated at 0.12 FTE secretaries, 0.62 FTE genetic counselors and 0.08 FTE cancer geneticists and the procedure was shown to be cost-effective. This new procedure allows the suppression of up to 1/3 of appointments, guarantees priority for appointments with therapeutic impact and optimizes the interaction and breakdown of tasks between genetic counselors and cancer geneticists.
- Published
- 2017
- Full Text
- View/download PDF